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Attaching targeting ligands on the surface of self-assembled drug delivery systems is the key request for a
controlled transport of the drug to a desired location. Most commonly, the amphiphilic molecules (block-
copolymers, lipids etc.) are therefore pre-functionalized before the self-assembly takes place. However,
this strategy cannot be applied, if it interferes with the self-assembly process, if the introduced functional
groups react with loaded cargo or if natural carriers like extracellular vesicles should be functionalized.
Here, we present the site-speciﬁc coupling of antibodies to the surface of amino group-terminated lipo-
somes via bio-orthogonal copper-free click chemistry after liposome formation. The present primary
amino groups were functionalized with a linker carrying a strained alkyne group for a bio-orthogonal
strain-promoted alkyne–azide cycloaddition (SPAAC) reaction where Cu(I) as a catalyst can be avoided.
Antibodies were site-speciﬁcally functionalized with azide moieties along the Fc region to avoid inter-
ference with the antigen binding sites. The liposome surface functionalization reaction was optimized by
precisely analyzing the number of available functional groups (both amine and alkyne), which often rep-
resents a challenge for self-assembled systems. By ﬁnally conﬁrming the successful antibody coupling,
we provide a facile and robust functionalization strategy, which can be applied to a wide range of self-
assembled systems and desired targeting antibodies maintaining physiological conditions throughout the
procedure.
1. Introduction
Self-assembled systems of amphiphilic molecules are nowa-
days applied as drug delivery vehicles as they are biocom-
patible and can transport hydrophilic as well as hydrophobic
cargos. Typically, such self-assembled systems can be categor-
ized into the main groups of polymer-based structures, lipid-
based structures and more recently introduced natural vesi-
cles.1 Polymer-based self-assembled systems consist of amphi-
philic block-copolymers, which typically form double-layers
and assemble into polymersomes or micelles.2–4 Regarding
lipid-based structures, liposomes, which are small artificial
vesicles consisting of one or more phospholipid bilayers, were
first introduced by Bangham et al. in the 1960s.5 They are still
of high interest as their composition is similar to natural
cellular membranes and as such have an extraordinary
biocompatibility.6–9 Basically, there are four major types of
liposomes: (1) MLVs, multilamellar vesicles with several lamel-
lar lipid phase bilayers, (2) SUVs, small unilamellar vesicles
with one lipid bilayer,10–14 (3) LUVs, large unilamellar vesicles,
and (4) cochleate vesicles.15
Compared to these conventional structures, “second-gene-
ration” vesicles are chemically modified to obtain specific pro-
perties such as a prolonged blood circulation time or targeting
capability. More specifically, vesicles are functionalized with
various targeting ligands such as antibodies, peptides, pro-
teins or aptamers, with a variety of surface engineering
techniques.14,16–18 These ligands are mostly chemically
attached to the vesicles through interaction of reactive groups
on the liposomes’ or polymersomes’ surface and specific
groups present in the ligand. For this purpose, the pre-modifi-
cation of various types of block-copolymers, lipids or chole-
sterol is often applied to introduce functional groups.19–24 One
example is the commercially available DBCO modified lipo-
some formulation (Immunosome®-DBCO). In this case, the
functional DBCO groups were directly introduced via the phos-
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pholipid before the liposomes’ self-assembly. In a following
reaction, azide containing peptides or proteins can be immobi-
lized in the liposomes’ surface.
However, direct lipid or polymer functionalization might
not be applicable when the self-assembly of the vesicle struc-
ture is disturbed by the chemical modification of one com-
ponent. Similarly, pre-functionalization is not advisable when
the functional groups should only be present on the outer
vesicle surface to avoid reactions with sensitive cargos.
Additionally, the functional moieties, which are introduced
prior to self-assembly, might partially be buried in the hydro-
phobic environment of the formed membrane, as it was
demonstrated for polymersomes.20 Ultimately, also for pre-
assembled natural structures like extracellular vesicles25–27 a
diﬀerent functionalization strategy is required. Therefore, a
robust way is needed to enable bio-orthogonal and highly
specific functionalization of the vesicle surfaces after self-
assembly. Additionally, the proposed functionalization strategy
should allow for reliable surface characterization and precise
reaction control, which is challenging for preformed self-
assembled systems.
For a convenient and reliable coupling of two diﬀerent
functional moieties, click chemistry is widely used due to its
unique reaction properties: the procedure is very eﬃcient,
mild and can be carried out in aqueous reaction conditions.
Click chemistry is rapidly becoming a popular tool to functio-
nalize the surface of biomacromolecules, including viruses,
DNA, peptides, antibodies, liposomes, micelles, and nano-
particles with a wide variety of conjugates.28–30 There are two
well established bio-orthogonal coupling approaches: (1)
copper-catalyzed azide–alkyne cycloaddition (CuAAC) “click”
reactions, which are attractive as the reaction kinetics are favor-
able and azide-containing reagents are widely available11,29,31,32
(2) the strain-promoted alkyne–azide cycloaddition (SPAAC)
where the use of Cu(I) as a catalyst is avoided.33 This bio-orthog-
onal copper-free click chemistry oﬀers a great advantage regard-
ing the known deleterious eﬀects associated with copper in cell-
based studies and applications.34
In this work, we describe the formation of liposomes based
on lipid thin-film hydration followed by extrusion and sub-
sequent surface functionalization of lipid headgroups
(Scheme 1). To enable chemical modification via the SPAAC
Scheme 1 Schematic step-by-step illustration of liposome synthesis, surface functionalization and site-selective antibody attachment.
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approach, the lipid bilayer was composed out of cholesterol
and two diﬀerent phospholipids – 2-dioleoyl-sn-glycero-3-phos-
phoethanolamine (DOPE) and L-α-phosphatidylcholine (egg
PC) – with a molar ratio of 1 : 1 : 1. The formed liposomes were
characterized thoroughly to determine the exact number of
available surface primary amine groups (–NH2). Amino groups
were further coupled with dibenzylcyclooctyne–PEG4–NHS
ester to introduce a strained alkyne (DBCO group) to the lipo-
somes’ surface under diﬀerent reaction pH. Successful modifi-
cation with DBCO groups was proven by an anthracene azide
(Anth-N3) assay which was carried out for a precise DBCO
group quantification as well as analysis of the stability in
the aqueous solution. With this, we provide a universal
functionalization strategy for any NH2-terminated nanocarrier.
In addition, we give a detailed protocol on methods to monitor
each functionalization step. Next to this, the antibody
CD11c was site-specifically modified with azide groups by
transferase and UDP-N-azidoacetylgalactosamine (UDP-GalNAz).
Subsequently, the azide-functionalized antibody was coupled
to the DBCO-functionalized liposomes via bio-orthogonal
copper-free click chemistry (SPAAC). The successful coupling
was confirmed by a flow cytometry based binding assay using
fluorescently labeled secondary antibodies.
2. Experimental
2.1. Materials
All chemicals and materials were used as received. 1,2-Dioleoyl-
sn-glycero-3-phosphoethanolamine (DOPE) with ≥99.0% purity
(10 mg mL−1 in CHCl3), L-α-phosphatidylcholine (egg PC) with
purity ≥99.0% (100 mg mL−1 in CHCl3), cholesterol (powder,
BioReagent, ≥99%, Germany) and dimethylsulfoxide (DMSO)
were purchased from Sigma Aldrich (>99% purity, Germany).
The dye DiI Stain (1,1′-dioctadecyl-3,3,3′,3′-tetramethyl-
indocarbocyanine perchlorate) for labelling liposomes was pur-
chased from Thermo Fisher (catalog number: D282, Germany).
Dibenzylcyclooctyne (DBCO)–PEG4–NHS ester (cat. no.
CLK-A134-100) was purchased from Jena Bioscience (purity:
>95% (HPLC), Germany). Phosphate buﬀered saline (DPBS-
buﬀer, –Mg2+, –Ca2+) was procured from Sigma-Aldrich (USA),
while ethanol (99.5%) was acquired from Carl Roth, Germany.
A MilliQ device (Merck Millipore, Germany) was used to obtain
the demineralized water. Demineralized water was used for all
experiments. The antibodies anti-mouse CD11c (clone N418)
and the FITC-labeled goat anti-hamster (Armenian, clone
Poly4055) was purchased from Biolegend (0.5 mg mL−1). The
SiteClick™ Antibody Azido Modification Kit was obtained
from Thermo Fisher (catalog number: S20026, America).
2.2. Liposome preparation
Preparation of the thin film. Amine group-terminated lipo-
somes were prepared from cholesterol (Chol) and two diﬀerent
phospholipids: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine
(DOPE) and L-α-phosphatidylcholine (egg PC) with a molar
ratio of egg PC : DOPE : Chol = 1 : 1 : 1 by film hydration fol-
lowed by extrusion. Briefly, both lipids and cholesterol stock
solutions in chloroform were prepared at a concentration of
10 mg mL−1. Then, 835 µL, 767 µL and 398 µL of the egg PC,
DOPE and Chol solutions, respectively, were added into a
50 mL round-bottomed flask with an additional 2 mL of a
mixture of chloroform with 1 vol% EtOH. The mixture was
dried with a rotary evaporator at a reduced pressure of
450 mbar and 3 mbar each for half an hour at 42 °C.
Subsequently, the flask was placed in a vacuum oven for
1 hour to remove organic solvent residues (images of the film
formation procedure, see Fig. S1†).
Hydration of the thin film and extrusion. A volume of 4 mL
PBS buﬀer (0.1 M, pH = 7.4) was added into the flask and the
mixture was stirred over night at 550 rpm (Fig. S1†). Then the
mixture was sonicated in a water bath for 20 min. In order to
obtain small unilamellar liposomes, extrusion was performed.
The liposome solutions were extruded through two polycarbo-
nate membranes with pore sizes of 800 nm, 400 nm and
200 nm a number of 11 times at each step. Afterwards, the
liposome samples were stored at 4 °C until further use.
2.3. Liposome characterization
Dynamic light scattering (DLS). Generally, the average size
and the size distribution of all liposome samples was deter-
mined with diluted dispersions (10 μL sample with a solid
content of 0.35 wt% were diluted in 200 µL PBS buﬀer) with a
Zetasizer Nano S90 (Malvern Panalytical GmbH, Germany) at
20 °C. In order to obtain also the angular dependent
hydrodynamic radius (Rh), radius of gyration (Rg) and structure
parameter of non-functionalized liposomes, multi-angle DLS
was performed with an ALV spectrometer (ALV-GmbH,
Germany). The set-up consisted of a goniometer and an ALV/
LSE-5004 multiple-tau full-digital correlator with 320 channels.
As a light source a He–Ne laser was used at a wavelength of
632.8 nm. The samples were filtered through Millex-LCR
0.45 μm syringe filters (Merck, Germany) into cylindrical
quartz cuvettes (18 mm diameter, Hellma, Germany). The cuv-
ettes were cleaned in an acetone fountain prior to usage for
removing dust. Liposome samples were prepared in a concen-
tration of 0.003 mg mL−1 in PBS. The CONTIN algorithm35 was
used for data analysis.
Zeta potential. A Zetasizer Nano Z (Malvern Panalytical
GmbH, Germany) with disposable folded capillary cells was
used to determine the zeta-potential (ζ-potential) of the
various liposome samples. Basically, 10 µL of a dispersion of
each liposome sample (3.5 µg mL−1) were diluted with 1 mL of
a 1 mM potassium chloride (KCl) solution. The measurement
was performed at 25 °C after 2 min of equilibration. Each
measurement was repeated in triplicate and mean values as
well as standard deviations were calculated.
Cryogenic transmission electron microscopy (cryo-TEM). For
the visualization of the morphology of synthesized liposomes,
cryo-TEM measurements were performed. The liposome
sample (dispersed in PBS) was placed onto a 400 mesh copper
grid covered with lacey film, which was treated with oxygen
plasma to make it hydrophilic, and immobilized using high
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pressure freezing (Engineering Oﬃce M. Wohlwend GmbH,
Switzerland). The specimen (sapphire discs with cells) was
enclosed and protected in a small volume between two speci-
men carriers and locked inside the specimen pressure
chamber by blotting two times for 3 seconds each. Liquid
nitrogen was used as cooling medium. After the preparation,
the samples were carefully transferred into the liquid nitrogen
for further imaging.
Quantification of primary amine groups on the surface of
liposomes. The amount of NH2 groups present on the lipo-
somes’ surface was determined based on a fluorescamine
assay (FA assay). Hexylamine, which contains primary amine
groups, was selected as a reference for establishing the stan-
dard calibration curve. For the assay, 250 µL fluorescamine
stock solution (concentration of 0.3 mg mL−1) and 25 µL
sample solution (H2O as the control) as well as 725 µL borate
buﬀer (0.1 M, pH = 9.5) were added into a 2 mL Eppendorf
tube. The mixture was vortexed (Heidolph REAX2000 at
maximum speed) for 30 seconds and then immediately ana-
lyzed in a plate reader (Tecan AG, Switzerland) at 25 °C by
exciting at 410 nm and detecting the fluorescence emission at
470 nm. All fluorescence measurements were repeated three
times (3 × 100 µL in a well of a 96-well-plate).
2.4. Conjugation of DBCO groups to liposome surface via
NHS ester reaction
Firstly, a dibenzylcyclooctyne (DBCO)–PEG4–NHS ester (Mw =
388.37 g mol−1) stock solution was prepared by dissolving
10 mg DBCO–PEG4–NHS ester in 250 µL of dry DMSO to
obtain a final concentration of 40 mg mL−1. Secondly, in order
to compare the DBCO conjugation eﬃciency, diﬀerent reaction
parameters were under consideration: (1) the molar ratio of
added DBCO–PEG4–NHS ester to amine groups (–NH2) was
varied to be 1 : 1, 3 : 1 and 6 : 1; (2) the reaction pH was varied
from 7.1 to 7.6 to 8.2. To achieve the diﬀerent coupling ratios,
126 µL, 63 µL or 21 µL of DBCO stock solution (concentration:
40 mg mL−1) were added into 500 µL of liposome sample
(solid content: 0.35 wt%), separately. The diﬀerent reaction pH
was adjusted by addition of 0.5 M NaOH or 0.1 M HCl solu-
tion. All the NHS ester conjugation reactions were carried out
by firstly vortexing for 20 s and then stirring (700 rpm) over
night at room temperature. Afterwards, the liposomes were
purified from excess functionalization reagent and organic
solvent by centrifugation at 20 000g and 4 °C for 1 h. The lipo-
somes were then redispersed in PBS. This washing procedure
was performed for a total of three times (see Fig. S2†).
2.5. Quantification of the DBCO groups on the liposomes’
surface
An anthracene-azide (Anth-N3) assay was performed to deter-
mine the DBCO conjugation eﬃciency. For the Anth-N3 stock
solution (needs to be freshly prepared before the assay):
1.8 mg Anth-N3 yellow powder was added into 1.05 mL dry
DMSO and covered with aluminum foil. The modified lipo-
somes (solid content: 0.35–0.42 wt%, ∼3.5 mg mL−1) were dis-
persed in PBS buﬀer (0.1 M, pH = 7.4). The mixture solutions
were vortexed for 20 s with maximum speed after addition of 5
diﬀerent sample types into 1.5 ml Eppendorf tubes: (a–b)
17.3 µL Anth-N3/32.6 µL DMSO; (c–d) 25 µL liposome dis-
persion/17.3 µL Anth-N3/7.63 µL DMSO; (e) 25 µL liposome
dispersion/25 µL DMSO. All the samples had the same total
volume of 50 µL, were covered with aluminum foil and placed
on the shaker over night at 25 °C. For the fluorescence intensity
measurement by the plate reader (Ex: 370 nm, Em: 414 nm), all
the mixtures were separated into two groups: 10 times dilution
and 100 times dilution by DMSO. Namely, 10 µL of the samples
were added into 90 µL DMSO and 1 µL of the samples added
into 99 µL DMSO. All the measurement data were calculated
according to a previously reported procedure.24
2.6. Site-specific, enzymatic modification of antibodies
Anti-mouse CD11c antibodies (clone N418, Biolegend, 0.5 mg
mL−1) were modified site-specifically on the heavy chain Fc
parts with an azide using the Site Click™ Antibody Azido
Modification Kit from Thermo Fisher. In the first step, a buﬀer
exchange was performed. Therefore, 250 µg of the anti-mouse
CD11c antibody (500 µL, 0.5 mg mL−1) were loaded onto an
antibody concentrator (supplemented with the kit) and centri-
fuged for 6 min at 5000g. The flow-through was discarded and
450 µL of antibody preparation buﬀer (supplemented with the
kit) were added and centrifuged for 8 min at 5000g. For anti-
body recovery, the concentrator was inverted, placed into a
fresh lo-bind Eppendorf tube (2 mL) and centrifuged (3 min,
1000g) to obtain a concentrated antibody solution (80 µL, 2 mg
mL−1, 160 µg). Afterwards, galactosidase (supplemented with
the kit, 10 µL) was added to the antibody solution and incu-
bated overnight at 37 °C to remove the galactose residues on
the carbohydrate domain at the Fc region. Further, the azide
group was enzymatically attached to the carbohydrate modi-
fied-antibody. Therefore, 75 µL of H2O, 12.5 µL of 20× Tris
buﬀer (pH = 7), 25 µL of buﬀer additive and 80 µL of GalT
(Y289L) enzyme as well as the prepared carbohydrate modified
antibody were added to a tube containing UDP-GalNAz (all
components supplemented with the kit) and incubated over-
night at 30 °C. To remove excess UDP-GalNAz, the azide-modi-
fied antibody was purified with a large antibody concentrator
(supplemented with the kit). Therefore, the large antibody con-
centrator was pre-washed with 1 mL of 1× Tris (pH = 7) via cen-
trifugation (10 min, 1200g). Afterwards, the azide-modified
antibody was loaded onto the large antibody concentrator and
1.6 mL of 1× Tris (pH = 7) was added. The concentrator was
centrifuged (6 min, 1200g) and the flow-through was dis-
carded. This step was repeated three times. Finally, the con-
centrator was inverted, placed into the conical collection tube
and centrifuged for 3 min at 1000g. The azide-modified anti-
body (∼40 µL, 2.6 mg mL−1) was recovered, transferred to a
fresh lo-bind Eppendorf tube (1.5 mL) and stored at 4 °C.
2.7. Liposome surface functionalization with antibody via
copper-free click chemistry
167 µL DBCO-liposome (∼3 mg mL−1 assumption = 500 µg)
and 6.7 µL of azide-modified anti-mouse CD11c-antibody
Paper Polymer Chemistry























































































(2.6 mg mL−1, 17.5 µg) were mixed and incubated overnight at
room temperature. In order to remove unconjugated anti-
bodies, the dispersion was centrifuged (20 000g, 15 min, 4 °C)
and washed with 500 µL of PBS. This step was repeated three
times and in the end the liposome-antibody pellet was resus-
pended in 80 µL of PBS.
2.8. Detection of antibodies on the liposomes’ surfaces via
flow cytometry
The successful coupling of the anti-mouse CD11c antibodies
on the liposomes’ surfaces was confirmed by our previously
established flow cytometry protocol.36 Therefore, liposomes
with DBCO or liposomes with attached antibodies (2 µL, 3 mg
mL−1, 6 µg) were incubated with FITC-labeled goat anti-
hamster (Armenian, clone Poly4055, Biolegend, 0.5 mg mL−1,
2 µL, 1 µg) for 30 min at room temperature in the dark.
Afterwards, the mixture was filled up with PBS (1 mL). Flow
cytometry measurements were performed on an Attune Nxt
flow cytometer (Thermo Fisher Scientific) equipped with four
lasers (405, 488, 561 and 637 nm) and 16 channels (VL1-4,
BL1-4, YL1-4, RL1-4). Liposomes were displayed in a logarith-
mic scale in a dot plot (SSC vs. YL1). Further, the number of
FITC-labeled liposomes was quantified in a histogram via the
median fluorescent intensity (MFI) and amount of FITC posi-
tive liposomes (%).
2.9. Nano diﬀerential scanning fluorimetry (nanoDSF)
Measurements were performed with the Prometheus NT.48
device from NanoTemper Technologies GmbH (Munich,
Germany) using high sensitivity glass capillaries (NanoTemper).
The excitation power was set to 50% for all experiments and a
temperature ramp from 20 °C to 95 °C with a heat rate of 1 °C
min−1 was used. The capillary was loaded with 10 µL of the
antibody (0.5 mg mL−1). The fluorescence signal at a wave-
length of 330 nm and 350 nm was recorded. For data analysis,
the ratio of the 350 nm to the 330 nm channel was plotted
against temperature. The melting point (TM) was determined
from the plot of the first derivative of the fluorescence signal.
2.10. SDS-PAGE
The antibody solution (3 µg in a total volume of 26 µL) was
mixed with 4 μL of reducing agent and 10 μL of sample buﬀer.
Samples were loaded onto a NuPAGE Novex 10% bis–tris gel
and the gel was run for 1 h at 120 V. SeeBlue Plus2 Pre Stained
Standard was used as marker. Protein bands were visualized
with the SilverQuest Silver Staining Kit according to the manu-
factures’ instruction. All consumables were obtained from
Thermo Fisher Scientific, Waltham, MA.
2.11. Functionalization of azide-modified antibodies with
DBCO–PEG5 ka
The azide-modified antibody (0.5 mg mL−1, 5 µL) was incu-
bated with DBCO–PEG5 ka dissolved in DMSO (2.5 mg mL
−1,
1 µL, Iris Biotech GmbH, Germany) overnight at room tem-
perature. The resulting PEGylated antibody conjugate was
further applied to SDS-PAGE.
2.12. Functionalization of azide-modified antibodies with
DIBO–PE
The azide-modified antibody (0.5 mg mL−1, 15 µL) was incu-
bated with DIBO–PE (11.25 µL, supplemented with the Site
Click™ Antibody Labeling Kit from Thermo Fisher) overnight
at room temperature. The PE-conjugated antibody was purified
according to the manufactures’ instruction.
2.13. DC2.4 cell binding assay
Murine dendritic cells (DC2.4, Merck, Germany) were cultured
in Iscove’s Modified Dulbecco’s Medium (IMDM), sup-
plemented with 5% fetal bovine serum (FBS), 1% penicillin
(100 U mL−1) and streptomycin (100 mg mL−1) as well as 1%
2-mercaptoethanol (100×), in an incubator with 37 °C and 5%
CO2 humidity (CO2 Incubator C200, Labotect). For the cell
binding assay, 100 000 DC2.4 cells were incubated with the PE
modified anti-mouse CD11c antibody (0.34 mg mL−1, 1 µL) for
30 min at 4 °C in a total volume of 100 µL PBS. For the block-
ing assay, DC2.4 cells were treated with unlabeled anti-mouse
CD11 antibody (2 mg mL−1, 5 µL) for 30 min at 4 °C in a total
volume of 100 µL PBS. All samples were filled up with 900 µL
of PBS and run on an Attune NxT Flow cytometry. The cell
population was selected with a FSC/SSC scatter plot, excluding
cell debris populations. The gated events were evaluated by the
fluorescent signal (YL1 channel for PE) expressed as median
fluorescence intensity (MFI).
3. Results and discussion
3.1. Liposome preparation and characterization
The liposomes used for this study were produced by lipid dry-
film hydration followed by extrusion with an original lipid con-
centration of 5 mg mL−1 (Fig. 1.A). This method is applicable
to both lipids and block-copolymers for the formation of self-
assembled vesicles. The final dispersion in PBS buﬀer yielded
liposomes with very narrow size distribution and a hydrodyn-
amic radius (Rh) of 97 ± 10 nm (Fig. 1.B, Fig. S3†). For the rehy-
dration, also deionized water instead of PBS buﬀer can be
used, which however changes the obtained final size slightly
due to the diﬀerent ionic strength (see Fig. S4†). In this case,
PBS was chosen for conducting all further experiments to
maintain a physiological sample environment. The zeta poten-
tial of the liposomes yielded a slightly negative surface charge
of −16 ± 7 mV at pH 7 (zeta potential measurements see
Fig. S5†). The final synthesized liposomes were obtained with
a solid content of about 0.35–0.38 wt% (∼3.5–3.8 mg mL−1)
after extrusion, which corresponds to a concentration of about
1.0 ± 0.2 × 1013 liposomes mL−1. The morphology of liposomes
was then analyzed by cryo-TEM and the images demonstrated
spherical nanosized unilamellar liposomes with a homo-
geneous size distribution (Fig. 1.C and D) and a membrane
thickness of 4.0 ± 0.5 nm. Additionally, the prepared lipo-
somes were characterized with regards to their number of
accessible functional amine groups on the surface, which is
extremely important to yield defined conditions for the sub-
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sequent coupling reactions. According to the fluorescamine
assay (reaction scheme see Fig. S6†), the synthesized egg PC/
DOPE/Chol liposomes contained (1.68 ± 0.01) × 1018 NH2
groups mL−1 corresponding to (1.6 ± 0.3) × 105 NH2 groups per
liposome.
3.2. Conjugation of DBCO groups to liposomes via NHS ester
reaction
The DBCO–PEG4–NHS ester was selected for liposome surface
modification to introduce active alkyne groups, which react
specifically and eﬃciently with a primary amine (–NH2) at pH
7.0–8.5 to form a covalent bond (see Fig. 2A). This is especially
desired since amine groups can also easily be introduced into
e.g. polymersomes and are present on other natural carrier
systems such as extracellular vesicles, where they mostly
appear in the form of membrane proteins. Like this, the
functionalization strategy could directly be adapted for all
kinds of self-assembled structures. The hydrophilic polyethyl-
ene glycol (PEG) spacer arm imparts water solubility and pro-
vides a flexible connection that minimizes steric hindrance
involved with ligation to complementary azide-containing
molecules. This spacer can further be varied in length to later
provide optimal accessibility of the coupled compound.
At this point, it is worth to point out that the liposomes
(including all other self-assembled structures comprised of
amphiphilic molecules) are sensitive towards organic solvents,
which can cause liposome aggregation. Thus, the DBCO–
PEG4–NHS ester was dissolved in DMSO in a very high concen-
tration (40 µg µL−1) so that only a minimal addition of organic
solvent DMSO was required to carry out the functionalization
reaction successfully. With this low amount of organic solvent,
no aggregation of liposomes was observed.
The reaction of NHS esters with amines is strongly pH-
dependent: on one hand at a low pH, the amino groups on the
liposomes’ surface will be protonated and therefore the reactiv-
ity is decreased. On the other hand, if the reaction is per-
formed at higher pH, hydrolysis of the NHS ester will be very
fast and thus the functionalization yield of liposomes will be
reduced. Therefore, optimization of the pH value for this reac-
tion is crucial. In our work, diﬀerent reaction pH values (7.1,
7.6 and 8.2) as well as diﬀerent molar ratios of DBCO/NH2
groups (1 : 1, 3 : 1 and 6 : 1) were compared carefully with
regards to the modification eﬃciency.
3.3. Quantification of DBCO groups via an anthracene-azide
(Anth-N3) assay
For further antibody click reaction, it was important to deter-
mine the total number of DBCO groups that could participate
in a further click reaction. Therefore, a click reaction of Anth-
N3 (9-(azidomethyl) anthracene) to the Lipo-DBCO samples
was performed for the quantification of the surface alkyne
groups. This procedure was described in literature by Baier
et al.31 The Anth-N3 click reaction mechanism is shown in
Fig. 2.B. Anth-N3 itself is already fluorescent (I0, in eqn (1))
(Ex: 370 nm, Em: 414 nm). However, after the click reaction
with the Lipo-DBCO the quantum yield increases by a factor of
48 resulting in an increase of the overall fluorescence intensity
(I, in eqn (1)) due to a photoinduced electron transfer (PET)
eﬀect. A 48-fold increased quantum yield was used for our cal-
culation for the following reason: the quantum yield of the
azide is 0.02 and the newly formed triazole has a quantum
Fig. 1 (A) Schematic overview of liposome preparation. (B) Physicochemical characterization of synthesized liposomes. C, (D) cryo-TEM images of
liposomes. From images with high magniﬁcation (D) the membrane thickness of the liposomes d was determined.
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yield of 0.95–0.97 based on literature reports.37 Therefore, the
ratio and increase of the quantum yield is 0.96/0.02 = 48. The
amount of DBCO groups on the liposome surface could
further be quantitatively calculated via eqn (1) and (2). In the
equations, Ω represents the fluorescent enhancement and
n(react-Azido) the total amount of reacted azide groups, which








In the Anth-N3 assay, the quantitative determination
38–40 of
DBCO groups on the liposomes’ surface was performed for the
three diﬀerent DBCO/NH2 group ratios 1 : 1, 3 : 1 and 6 : 1 with
three diﬀerent reaction pH values (7.1, 7.6 and 8.2) (as shown
in Fig. 2C). From the measured fluorescence, the number of
DBCO groups per liposome were calculated. Additionally, the
DBCO conjugation stability after the reaction with the lipo-
somes was determined (Fig. 2C and D). We found that the
Fig. 2 Quantiﬁcation of DBCO groups on the liposomes’ surface. Schematic illustration of (A) the functionalization procedure with a DBCO–PEG4–
NHS ester. (B) The anthracene-azide assay: the coupling of anthracene provides ﬂuorescence emission proportional to the number of DBCO groups.
(C) Anthracene-azide assay quantiﬁcation results for diﬀerent reaction conditions (varied DBCO/NH2 group ratio and diﬀerent reaction pH). (D)
DBCO group quantiﬁcation after diﬀerent storage times.
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highest modification eﬃciency is observed for a 3-fold molar
ratio of DBCO to liposomes for the same reaction pH value. In
this case, the maximum conjugation eﬃciency is ∼20%. In
addition, the conjugation eﬃciency increased slightly along
with the increasing reaction pH for all reaction molar ratios
between DBCO/NH2. Next to this, the stability of the DBCO
groups after the liposome modification was investigated
(Fig. 2D). The value of DBCO groups per liposomes decreased
by more than 50% after 7 days compared to the fresh samples.
Moreover, some floccules started to appear within the Lipo-
DBCO suspension, especially for the molar ratio DBCO/NH2 =
6 : 1 after 7 days. This means that further coupling by click
chemistry ideally should be performed within the same day.
Since during this reaction optimization step it was found that
the ratio of DBCO/NH2 = 6 : 1 did not result in further increase
of the reaction yield, but rather in a significant decrease, sub-
sequent coupling of the chosen antibody was only performed
for the 1 : 1 and 3 : 1 ratio conditions, which were coupled at a
reaction pH of 8.2.
3.4. Antibody functionalization and coupling to liposomes
via copper-free click reaction
Most widely in literature, antibodies are functionalized via
NHS-chemistry.41–43 In this case, the functional group is
attached on the lysine residues or the N-termini of the anti-
bodies. This functionalization strategy is highly unspecific as
Fig. 3 Antibody functionalization and attachment to surface-modiﬁed liposomes. (A) Enzymatic removal of galactose from the Fc-part of the
CD11c-antibody with galactosidase. (B) Site-speciﬁc, enzymatic attachment of an azide functionality using UDP-N-azidoacetylgalactosamine
(UDP-GalNAz) to the sugar residues on the Fc-part of the CD11c-antibody (C) bio-orthogonal copper-free click reaction to attach the azide-
modiﬁed antibody on the DBCO-modiﬁed liposome surface.
Paper Polymer Chemistry























































































lysine residues are distributed over the whole antibody
sequence including the antigen-binding site (Fab region).44
Next to this, the two N-termini of the antibody are also located
within the Fab region. Therefore, introducing functional
groups along those groups can cause a loss of the antibody
functionality and decreased cellular recognition.36 Therefore,
we chose a site-selective antibody functionalization strategy
to overcome the loss of binding specificity and antibody
functionality. Monoclonal antibodies have two conserved
N-glycosylation sites on the heavy chain of the fragment crys-
tallizable region (Fc-part).45 It is known that N-glycosylation
occurs at the amino acid asparagine (Asn) in the position Asn-
297.46 Therefore, here we used a functionalization strategy,
which allows the site-selective attachment of a maximum of
four azide groups (two per heavy chain) at the Asn-297 position
to the CD11c antibody. It is a two-step protocol, where in the
first step galactose is enzymatically removed from the sugar-
tree and an N-acetylglucosamine residue is exposed (Fig. 3.A).
In a second step, an azide-labeled sugar derivate (GalNAz,
N-azidoacetylgalactosamine-tetraacylated) is enzymatically
attached via the galactose-specific transferase (β1,4-galactosyl-
tranferase mutant Y289L-Gal-T1) to the glycans of the antibody
(Fig. 3.B). This method was first developed for the site-selective
radiolabeling of antibodies.47 In this case, the azide-modified
antibody was conjugated with a desferrioxamine-modified di-
benzocyclooctyne (DIBO) in a copper-free click reaction and
89Zr was further added for radiolabeling. The same antibody
functionalization strategy was also applied for engineering
site-specific antibody–drug-conjugates.48,49
To investigate the structural and functional integrity of the
azide-modified antibody compared to the native antibody,
nanoDSF measurements, SDS-PAGE (Fig. 4) and a cell binding
assay (Fig. S7†) were performed. nanoDSF is a method to deter-
mine protein stability based on the intrinsic fluorescence
intensity of a protein upon heating. The characteristic melting
temperature (TM) is defined at the point, where 50% of the
protein is unfolded. For the native anti-mouse CD11c antibody
(blue) and the azide-modified antibody (orange), the thermal
behavior determined by nanoDSF was highly comparable
(Fig. 4A). Next to this, the melting temperature before and
after functionalization was about 67 °C, which is in accordance
with literature reports for other antibodies.50 This indicates
that the azide modification of the antibody had no major
impact on the structural properties of the antibody.
Next to this, the unmodified (1) and modified (2) antibody
was applied to SDS-PAGE (Fig. 4C) to investigate molecular
Fig. 4 Characterization of the azide-modiﬁed antibody. (A) and (B) nanoDSF measurements of the unmodiﬁed and azide-modiﬁed anti-mouse
CD11c antibody (10 µL, ∼0.5 mg mL−1). The antibody was heated up (1 °C min−1) from 20 °C to 95 °C and the intrinsic ﬂuorescence intensity at
330 nm and 350 nm was recorded. The ratio of the ﬂuorescence intensity (350/330 nm, A) and the ﬁrst derivation (B) is plotted. The melting temp-
erature TM is determined from the maximum of the 1
st derivation of the ratio. (C) SDS-PAGE of unmodiﬁed (1), azide modiﬁed CD11c (2) and
PEGylated CD11c antibody (3). Proteins (3 µg) are reduced, applied to an SDS-PAGE and protein bands are visualized by Silver Staining.
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weight diﬀerences and possible degradation products after
antibody functionalization. We could observe no significant
diﬀerence for the azide-modified antibody compared to the
unmodified one. To verify the successful azide functionali-
zation of the antibody, a model reaction with a DBCO-PEG-
linker (5 kDa) was carried out and the resulting conjugate
was applied to SDS-PAGE. In lane 3 (Fig. 4C) there are two
additional protein bands visualized, which correspond to the
heavy chain (HC) fragment of the antibody (50 kDa) modified
with one DBCO–PEG5 kDa (+5 kDa) and thus one azide group
or an HC fragment conjugated with two DBCO–PEG5 kDa
(+10 kDa) and thus two azide groups per HC fragment. This
means for the full antibody (having two HC fragments) the
labeling eﬃciency is between 2–4 azides per antibody. This is
also in agreement with literature reports, stating a labeling
degree of 2.7 ± 0.2 GalNAz residues per antibody.47
To determine the functional binding properties of the
modified antibody, a DIBO-modified fluorescent dye (PE) was
incubated with the azide-modified anti-mouse CD11c anti-
body. Murine dendritic cells (DC2.4), which express CD11c
antigen, were incubated with the PE-modified anti-mouse
CD11c antibody for 30 min at 4 °C (Fig. S7†). The PE-modified
anti-mouse CD11c antibody strongly bound to the DC2.4 cells.
To confirm the antibody specificity, cells were pre-treated with
free unlabeled anti-mouse CD11c antibody (blocking assay). In
this case, the PE-modified anti-mouse CD11c antibody was not
able to bind to the DC2.4 cells proving the receptor specificity
of the PE-modified anti-mouse CD11c antibody.
In a last step, the azide-modified anti-mouse CD11c anti-
bodies were incubated with the DBCO-functionalized lipo-
somes overnight at room temperature (Fig. 3C). Via the bio-
orthogonal copper-free click reaction (SPAAC), it was possible
to covalently immobilize the azide-modified antibodies on the
DBCO-functionalized liposomes’ surface.
To prove the successful coupling, flow cytometry measure-
ments were performed using our previously established proto-
col.36 Here, we chose a fluorescently-labeled secondary anti-
body (FITC-anti hamster antibody), which specifically binds to
the immobilized anti-mouse CD11c antibodies (clone N418,
host species Armenian Hamster) on the liposomes’ surface by
recognition of the Fc-region (Fig. 5A). As a control, liposomes
functionalized with DBCO only were incubated with the FITC-
labeled secondary antibody.
As a result of the flow cytometry analysis, we detected a
high amount of FITC-fluorescence positive liposomes for Lipo-
CD11c (∼60% to 80%, Fig. 5B). In contrast, there was a very
low unspecific binding of the FITC-labeled secondary antibody
to the Lipo-DBCO samples (<20%) as expected without any
Fig. 5 Veriﬁcation of antibody presence on the liposomes’ surface. (A) Schematic illustration of the ﬂow cytometry measurements for the antibody
quantiﬁcation on the liposome surface. (B) and (C) Flow cytometry measurements for liposomes functionalized with anti-mouse-CD11c antibodies.
A secondary labeled FITC-anti-hamster antibody was used to detect the antibodies on the liposome surface. Diﬀerent reaction conditions (ratio
between DBCO/NH2 groups 1 : 1 or 3 : 1) were investigated. The number of FITC-positive liposomes in % (B) or the median ﬂuorescence intensity
(MFI) is shown (C).
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attached proteins being present. Along with the quantification
of the DBCO groups on the liposomes’ surface (Fig. 2B), a
higher amount of antibodies was detected for liposomes modi-
fied with the DBCO/NH2 = 3 : 1 ratio (Fig. 5C). This means that,
indeed, the number of attached antibodies was also pro-
portional to the number of available DBCO groups on the lipo-
somes and the proposed coupling strategy provides precise
control over the obtained liposomal surface. It has to be noted,
however, that the exact number of antibodies per liposome
cannot be deducted from the fluorescence intensity, as the
unspecific binding also has to be taken into account. The
theoretical maximum number of antibodies per liposome was
calculated to be 42 (see Table S1†).
Finally, the liposome–antibody conjugates were again
characterized with regards to their physico-chemical properties
as shown in Fig. 6. The size and surface charge of the non-
functionalized as well as the functionalized liposomes was
compared for both coupling ratios DBCO/NH2 1 : 1 and 3 : 1.
As indicated in Fig. 6.A and C, the size of the liposomes
increased step-wise after functionalization. Coupling of the
DBCO groups and the antibody CD11c slightly enlarged the
liposomes hydrodynamic diameter from 194 nm up to 293 and
325 nm (1 : 1 and 3 : 1 DBCO/NH2 groups, respectively). There
are mainly two reasons: (1) for the DBCO conjugation/antibody
click reaction, the DBCO-liposomes and the liposome-antibody
conjugates have to be purified from free excess DBCO–PEG4–
NHS ester and further free unreacted antibodies by centrifu-
ging 3 times at 20 000g. During these washing steps, smaller
liposomes could also be removed. (2) Long chain molecule
PEG and DBCO groups as well as the attached antibodies
result in larger overall liposomes. Furthermore, we observed
that the zeta potential of the functionalized liposomes was
more negative compared to the non-functionalized surface.
After attachment of the CD11c antibodies, the zeta potential
approached a value of −25 mV (for the 3 : 1 DBCO/NH2 ratio),
which is typical for nanocarrier surfaces covered with proteins.
Finally, with the performed characterization approaches, we
are confident that we have presented a facile functionalization
approach for bio-orthogonal and site-specific attachment of
antibodies on a liposome surface. By making use of specific
quantification techniques, the available surface functional
groups can precisely be analyzed so that the click chemistry
reaction stoichiometry can be adjusted to yield an optimal
eﬃciency. With the site-specific antibody modification,
additionally it can be assured that the final conjugation
product carries recognizable antibody units, which is of impor-
tance for further application. The availability of the coupled
antibody could even be increased if necessary upon introduc-
Fig. 6 Physicochemical characterization of liposomes before and after functionalization with DBCO/antibodies. (A) Size of liposomes before/after
DBCO and antibody attachment using 1 : 1 and 3 : 1 DBCO/NH2 ratios. (B) Surface charge before and after liposome functionalization. (C) Overview
of the physicochemical properties of the liposomes for the diﬀerent reaction conditions.
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tion of a longer PEG linker, so that e.g. the adsorption of pro-
teins would not cover the targeting structures.
4. Conclusion
In this study, we have shown the synthesis of amine group-
terminated liposomes via lipid dry film rehydration followed
by extrusion. In contrast to common vesicle functionalization
approaches, which rely on pre-modification of lipids or block-
copolymers, we introduced further functional groups and per-
formed antibody coupling via bio-orthogonal copper-free click
chemistry after liposome self-assembly. For precise reaction
control and tunability, a fluorescamine assay (FA assay) and an
anthracen-azide (Anth-N3) assay were utilized to determine the
number of present NH2 groups as well as DBCO groups after
functionalization. The antibody, which was introduced as a
possible targeting structure, was modified site specifically at
the Fc fragment and coupled to the liposomes using the
strain-promoted alkyne–azide click (SPAAC) reaction. This
surface functionalization procedure oﬀers the advantage to be
transferred to all self-assembled systems bearing primary
surface amino groups without damaging the assembled struc-
ture because no large amounts of organic solvent are required
and the carriers can be kept in physiological conditions.
Amino groups can easily be introduced as end groups of block-
copolymers and are already present on natural structures such
as extracellular vesicles (in the form of membrane proteins).
Additionally, this type of antibody coupling is applicable for
all antibody types without the disadvantage of potentially cov-
ering or modifying the antigen binding sites. If needed, the
introduced PEG spacer can also be varied in length or type of
building block to provide additional characteristics like
enhanced stealth properties or better antibody accessibility. In
summary, this versatile vesicle surface functionalization strat-
egy is applicable for a wide range of drug delivery systems as
well as straightforward and robust in terms of handling.
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